Location History:
- Köln, DE (2008 - 2011)
- Cologne, DE (2011 - 2012)
Company Filing History:
Years Active: 2008-2012
Title: Michael Nix: Innovator in Electroporation Technology
Introduction
Michael Nix is a prominent inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of electroporation. With a total of four patents to his name, Nix has developed innovative methods for introducing biologically active molecules into cells.
Latest Patents
Among his latest patents is a buffer solution for electroporation, which includes a method for introducing biologically active molecules into animal or human cells using an electric current. This method involves suspending the cells and dissolving the biologically active molecules in a buffer solution that contains HEPES and at least 10 mmol·1 magnesium ions (Mg). The buffer solution is designed to have a buffer capacity of at least 20 mmol·1·pH at a change in pH from 7 to 8 and at a temperature of 25°C, with an ionic strength of at least 200 mmol·1. Another patent focuses on a buffer solution for suspending animal or human cells and dissolving biologically active molecules to facilitate their introduction into the cells using electric current. This buffer solution includes components such as sodium succinate, mannitol, and sodium lactobionate, and shares similar buffer capacity and ionic strength specifications.
Career Highlights
Michael Nix has worked with notable companies in the biotechnology sector, including Lonza Cologne GmbH and Amaxa AG. His experience in these organizations has allowed him to refine his expertise in electroporation and related technologies.
Collaborations
Throughout his career, Nix has collaborated with esteemed colleagues such as Gudula Riemen and Elke Lorbach. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Michael Nix is a key figure in the field of biotechnology, particularly in the development of electroporation technologies. His patents and collaborations reflect his commitment to advancing scientific knowledge and improving methods for cellular manipulation.